About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT01283295

Immune Monitoring and Assay Development in Organ Transplant Recipients

The purpose of this study to develop a well-characterized library of blood, biopsy tissue, and urine samples from transplant patients. Subjects without transplants will also be enrolled for comparison...

Lead sponsor: Emory University•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Shine Thomas, CRC

CONTACT

404-712-2004 [email protected]

Sponsors

Lead Sponsor

Emory University

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Recipients of or candidates for organ transplantation or organ donors for recipients under evaluation at Emory University or CHOA
•Normal volunteers to include individuals without any known end-stage organ disease who are not on any immunosuppressive medication, and individuals with conditions requiring immunosuppression (i.e. dermatological diseases) that do not require transplant therapies
•Ability to understand the purposes and risks of the study and willingly give written informed consent, or in the case of minors, ability to give minor assent (children older than 5 years of age), in conjunction with written guardian consent

Exclusion Criteria

•Patients who fail to meet the criteria for transplantation or post-transplant follow-up by Emory or Children's Healthcare of Atlanta physicians
•Any condition that, in the opinion of the attending physician, would place the patient at undue risk by participating. Specific conditions include but are not limited to anemia prohibitive of phlebotomy, coagulopathy or technical considerations that would prevent acquisition of sufficient tissue on biopsy for clinical use, or medical urgency preventing timely administration of the consenting process.

Related studies

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

NCT05318196 · Acute Kidney Injury, Chronic Kidney Diseases, and more

Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation

NCT07291258 · Solid Organ Transplantation, Pregnancy, and more

Biomarkers in Transplant Recipients to Improve Outcomes

NCT01163578 · Solid Organ Transplantation, Bone Marrow Transplantation

Leuven Tolerogenic Protocol for Intestinal Transplantation

NCT02314949 · Organ Transplantation, Intestine

Active Not Recruiting

Casting Light on HOst-cytomegaloviRUs Interaction in Solid Organ Transplantation

NCT05701228 · Cytomegalovirus Infections, Solid Organ Transplantation

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 8, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment5,000

Start dateNov 2007

Last updatedSep 8, 2023

Condition

Organ Transplantation Transplantation Immunology

Locations shown

Children's Healthcare of Atlanta

Atlanta, Georgia

Emory University

Atlanta, Georgia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 8, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions